CSIMarket
 


Agilent Technologies inc   (A)
Other Ticker:  
 

Agilent Technologies Inc 's Quick Ratio

A's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


Agilent Technologies Inc 's Cash & cash equivalent grew by 19.64 % in the IV Quarter 2023 sequentially, while Current Liabilities decreased, this led to improvement in Agilent Technologies Inc 's Quick Ratio to 0.99, Quick Ratio remained below Agilent Technologies inc average.

Within Laboratory Analytical Instruments industry 17 other companies have achieved higher Quick Ratio than Agilent Technologies Inc in forth quarter 2023. While Quick Ratio total ranking has improved so far during the IV Quarter 2023 to 1675, from total ranking in the third quarter 2023 at 1922.

Explain Quick Ratio?
How much Cash & cash equivalents A´s has?
What are A´s Current Liabilities?


A Quick Ratio (Oct 31 2023)
IV. Quarter
(Jul 31 2023)
III. Quarter
(Apr 30 2023)
II. Quarter
(Jan 31 2023)
I. Quarter
(Oct 31 2022)
IV. Quarter
Y / Y Current Liabilities Change -13.86 % -7.47 % -8.11 % 22.22 % 8.96 %
Y / Y Cash & cash equivalent Change 51 % 24.09 % -0.93 % 12.31 % -29.04 %
Quick Ratio MRQ 0.99 0.76 0.71 0.65 0.57
A's Total Ranking # 1675 # 1922 # 2230 # 1887 # 2576
Seq. Current Liabilities Change -8.92 % 5.64 % -13.95 % 4.03 % -2.16 %
Seq. Cash & cash equivalent Change 19.64 % 13.11 % -6 % 18.71 % -1.68 %



Quick Ratio forth quarter 2023 Company Ranking
Within: No.
Laboratory Analytical Instruments Industry # 18
Healthcare Sector # 678
Overall Market # 1675


Quick Ratio Statistics
High Average Low
2.43 1.46 0.56
(Jul 31 2015)   (Jul 31 2022)




Financial Statements
Agilent Technologies Inc 's Current Liabilities $ 1,603 Millions Visit A's Balance sheet
Agilent Technologies Inc 's Cash & cash equivalent $ 1,590 Millions Visit A's Balance sheet
Source of A's Sales Visit A's Sales by Geography


Cumulative Agilent Technologies Inc 's Quick Ratio

A's Quick Ratio for the trailling 12 Months

A Quick Ratio

(Oct 31 2023)
IV. Quarter
(Jul 31 2023)
III. Quarter
(Apr 30 2023)
II. Quarter
(Jan 31 2023)
I. Quarter
(Oct 31 2022)
IV. Quarter
Y / Y Current Liabilities TTM Growth -13.86 % -7.47 % -8.11 % 22.22 % 8.96 %
Y / Y Cash & cash equivalent TTM Growth 51 % 24.09 % -0.93 % 12.31 % -29.04 %
Quick Ratio TTM 0.77 0.67 0.62 0.61 0.62
Total Ranking TTM # 3736 # 4014 # 4013 # 1037 # 2214
Seq. Current Liabilities TTM Growth -8.92 % 5.64 % -13.95 % 4.03 % -2.16 %
Seq. Cash & cash equivalent TTM Growth 19.64 % 13.11 % -6 % 18.71 % -1.68 %


On the trailing twelve months basis A Cash & cash equivalent soared by 51 % in IV Quarter 2023 year on year, while Current Liabilities decreased to $1,603 millions, this led to increase in in Agilent Technologies Inc 's Quick Ratio to 0.77, Quick Ratio remained below A average.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Laboratory Analytical Instruments industry 27 other companies have achieved higher Quick Ratio than Agilent Technologies Inc . While Quick Ratio overall ranking has improved so far to 3736, from total ranking during the twelve months ending third quarter 2023 at 4014.

Explain Quick Ratio?
How much Cash & cash equivalents A´s has?
What are A´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Laboratory Analytical Instruments Industry # 28
Healthcare Sector # 1001
Within the Market # 3736


trailing twelve months Quick Ratio Statistics
High Average Low
2.14 1.41 0.48
(Jul 31 2018)   (June 30. 2015)




Companies with similar Quick Ratio in the quarter ending Oct 31 2023, within Laboratory Analytical Instruments Industry Quick RatioOct 31 2023 MRQ Cash & cash equivalentOct 31 2023 MRQ Current Liabilities
Standard Biotools Inc   2.49 $ 128.850  Millions$ 51.800  Millions
Lifeloc Technologies Inc   2.23 $ 2.137  Millions$ 0.959  Millions
Akoya Biosciences Inc   2.21 $ 78.595  Millions$ 35.523  Millions
Olink Holding Ab publ   2.18 $ 120.957  Millions$ 55.487  Millions
Eyepoint Pharmaceuticals Inc   2.13 $ 136.012  Millions$ 63.896  Millions
Cue Health Inc   1.91 $ 111.454  Millions$ 58.407  Millions
Bionano Genomics Inc   1.58 $ 63.582  Millions$ 40.194  Millions
Agilent Technologies inc   0.99 $ 1,590.000  Millions$ 1,603.000  Millions
Revvity Inc   0.99 $ 1,429.692  Millions$ 1,447.845  Millions
Kewaunee Scientific Corporation  0.56 $ 21.711  Millions$ 38.732  Millions
Accelerate Diagnostics Inc   0.56 $ 21.151  Millions$ 37.786  Millions
Thermogenesis Holdings Inc   0.45 $ 4.018  Millions$ 8.890  Millions
Scientific Industries Inc   0.37 $ 0.810  Millions$ 2.183  Millions
Bruker Corporation  0.34 $ 363.600  Millions$ 1,072.300  Millions
Precipio inc   0.31 $ 1.562  Millions$ 5.060  Millions
Harvard Bioscience Inc  0.22 $ 5.340  Millions$ 24.205  Millions

Date modified: 2023-12-21T15:22:55+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com